본문 바로가기
KERD
논문KCI 등재

Asparagi radix alleviates testosterone-induced benign prostatic hyperplasia by inhibiting 5α-reductase activity and androgen receptor signaling pathway

3

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

BACKGROUND/OBJECTIVES: Recently, herbal medicines have gained attention for the treatment of benign prostatic hyperplasia (BPH), a common disease in elderly men. In this study, we aimed to determine the effect of ethanol extract of Asparagi radix (EAR), whichis traditionally used to treat various diseases, on BPH development using a testosterone- induced BPH model. MATERIALS/METHODS: Testosterone propionate (TP)-treated Sprague–Dawley rats were used to establish a BPH model in vivo. EAR was orally administered along with TP, and finasteride was used as a positive control. All rats were sacrificed at the end of the experiment, and pathological changes in the prostate tissue and levels of key biomarkers associated with BPH pathogenesis were assessed. RESULTS: Oral administration of EAR significantly inhibited TP-induced BPH by reducing the prostate weight, lumen size, and epithelial thickness in a concentration-dependent manner. EAR also significantly abrogated the expression of 5α-reductase type 2 (SRD5A2), proliferating cell nuclear antigen, and prostate-specific antigen (PSA) induced by TP. Additionally, serum levels of testosterone, dihydrotestosterone, and PSA were elevatedin the TP-induced group but decreased in the EAR-treated group. EAR also decreased the expression levels of the androgen receptor (AR) and its coactivators in TP-induced BPH model rats. CONCLUSION: Our findings revealed that EAR protected against BPH by inhibiting5α-reductase activity and AR signaling pathway, suggesting its potential for BPH treatment.

Abstract

BACKGROUND/OBJECTIVES: Recently, herbal medicines have gained attention for the treatment of benign prostatic hyperplasia (BPH), a common disease in elderly men. In this study, we aimed to determine the effect of ethanol extract of Asparagi radix (EAR), whichis traditionally used to treat various diseases, on BPH development using a testosterone- induced BPH model. MATERIALS/METHODS: Testosterone propionate (TP)-treated Sprague–Dawley rats were used to establish a BPH model in vivo. EAR was orally administered along with TP, and finasteride was used as a positive control. All rats were sacrificed at the end of the experiment, and pathological changes in the prostate tissue and levels of key biomarkers associated with BPH pathogenesis were assessed. RESULTS: Oral administration of EAR significantly inhibited TP-induced BPH by reducing the prostate weight, lumen size, and epithelial thickness in a concentration-dependent manner. EAR also significantly abrogated the expression of 5α-reductase type 2 (SRD5A2), proliferating cell nuclear antigen, and prostate-specific antigen (PSA) induced by TP. Additionally, serum levels of testosterone, dihydrotestosterone, and PSA were elevatedin the TP-induced group but decreased in the EAR-treated group. EAR also decreased the expression levels of the androgen receptor (AR) and its coactivators in TP-induced BPH model rats. CONCLUSION: Our findings revealed that EAR protected against BPH by inhibiting5α-reductase activity and AR signaling pathway, suggesting its potential for BPH treatment.

참고문헌 (39)

  1. Chughtai B, "Benign prostatic hyperplasia", Nat Rev Dis Primers, 2, pp.16031~ (2016)
  2. Corti M, "Endocrine disruptors and prostate cancer", Int J Mol Sci, 23, pp.1216~ (2022)
  3. Loughlin KR, "The prostate as an endocrine organ : its modulation of serum testosterone", Urol Clin North Am, 49, pp.695~697 (2022)
  4. Vickman RE, "The role of the androgen receptor in prostate development and benign prostatic hyperplasia : a review", Asian J Urol, 7, pp.191~202 (2020)
  5. Chislett B, "5-α reductase inhibitors use in prostatic disease and beyond", Transl Androl Urol, 12, pp.487~496 (2023)
  6. Madersbacher S, "Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement : a mini-review", Gerontology, 65, pp.458~464 (2019)
  7. He W, "Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review", Front Endocrinol(Lausanne), 14, pp.1287212~ (2023)
  8. Gwon YN, "Comparing effects of α-blocker management on acute urinary retention secondary to benign prostatic hyperplasia : a systematic review and network meta-analysis", Prostate Int, 11, pp.91~99 (2023)
  9. Bapir R, "Effect of α-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis", Arch Ital Urol Androl, 94, pp.252~263 (2022)
  10. Müderrisoglu AE, "Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia", Expert Opin Drug Saf, 22, pp.1213~1224 (2023)
  11. Romero Pérez P, "Post-finasteride syndrome. Literature review", Arch Esp Urol, 75, pp.382~399 (2022)
  12. Ma Y, "Oligosaccharides from Asparagus cochinchinensis for ameliorating LPS-induced acute lung injury in mice", Food Funct, 15, pp.2693~2705 (2024)
  13. Sung JE, "Saponin-enriched extract of Asparagus cochinchinensis alleviates airway inflammation and remodeling in ovalbumin-induced asthma model", Int J Mol Med, 40, pp.1365~1376 (2017)
  14. Wang M, "Asparagus cochinchinensis : a review of its botany, traditional uses, phytochemistry, pharmacology, and applications", Front Pharmacol, 13, pp.1068858~ (2022)
  15. Wang L, "Physicochemical, rheological, antioxidant and immunological properties of four novel non-inulin(poly)saccharides from Asparagus cochinchinensis", Int J Biol Macromol, 258, pp.129034~ (2024)
  16. Zhang RS, "Furostanol saponins from Asparagus cochinchinensis and their cytotoxicity", Nat Prod Bioprospect, 11, pp.651~658 (2021)
  17. Xiong D, "Effects of root and stem extracts of Asparagus cochinchinensis on biochemical indicators related to aging in the brain and liver of mice", Am J Chin Med, 39, pp.719~726 (2011)
  18. Lei L, "Aqueous root extract of Asparagus cochinchinensis(Lour. )Merr. Has antioxidant activity in D-galactose-induced aging mice", BMC Complement Altern Med, 17, pp.469~ (2017)
  19. Lei L, "The antioxidant effect of Asparagus cochinchinensis(Lour. )Merr. shoot in D-galactose induced mice aging model and in vitro", J Chin Med Assoc, 79, pp.205~211 (2016)
  20. Kim HR, "Asparagus cochinchinensis extract ameliorates menopausal depression in ovariectomized rats under chronic unpredictable mild stress", BMC Complement Med Ther, 20, pp.325~ (2020)
  21. Lee HA, "Asparagus cochinchinensis stimulates release of nerve growth factor and abrogates oxidative stress in the Tg2576 model for Alzheimer’s disease", BMC Complement Altern Med, 18, pp.125~ (2018)
  22. Okesina KB, "Naringin from sweet orange peel improves testicular function in high fat diet-induced diabetic rats by modulating xanthine oxidase", uric acid signaling and maintaining redox balance, 2024, pp.40, 5~
  23. Hwangbo H, "Mixture of Corni Fructus and Schisandrae Fructus improves testosterone-induced benign prostatic hyperplasia through regulating 5α-reductase 2 and androgen receptor", Nutr Res Pract, 17, pp.32~47 (2023)
  24. Kazaoka A, "Pathological changes in various organs in HLA-B*57 : 01 transgenic mice with abacavir-induced skin eruption", Toxicol Res, 40, pp.223~235 (2024)
  25. Soejima S, "Swallowing-related muscle inflammation and fibrosis induced by a single dose of radiation exposure in mice", Lab Anim Res, 40, pp.12~ (2024)
  26. Li Y, "The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia : a systematic review and meta-analysis", Transl Androl Urol, 11, pp.313~324 (2022)
  27. Smith AB, "Finasteride in the treatment of patients with benign prostatic hyperplasia : a review", Ther Clin Risk Manag, 5, pp.535~545 (2009)
  28. McNally CJ, "Biomarkers that differentiate benign prostatic hyperplasia from prostate cancer : a literature review", Cancer Manag Res, 12, pp.5225~5241 (2020)
  29. Suarez Arbelaez MC, "The emerging role of the urinary microbiome in benign noninfectious urological conditions : an up-to-date systematic review", World J Urol, 41, pp.2933~2948 (2023)
  30. Cózar JM, "The role of prostate-specific antigen in light of new scientific evidence: an update in 2020", Actas Urol Esp(Engl Ed), 45, pp.21~29 (2021)
  31. Varaprasad GL, "Recent advances and future perspectives in the therapeutics of prostate cancer", Exp Hematol Oncol, 12, pp.80~ (2023)
  32. Li X, "Androgen receptor cofactors : a potential role in understanding prostate cancer", Biomed Pharmacother, 173, pp.116338~ (2024)
  33. Sharifi N, "Androgen receptor modulation : lessons learned from beyond the prostate", Cancer Biol Ther, 6, pp.1358~1359 (2007)
  34. Hu YC, "Correction : functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer", J Biol Chem, 295, pp.17382~ (2020)
  35. Daniels G, "Androgen receptor coactivators that inhibit prostate cancer growth", Am J Clin Exp Urol, 2, pp.62~70 (2014)
  36. Wang XL, "Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells", Acta Pharmacol Sin, 32, pp.338~344 (2011)
  37. Culig Z, "Androgen receptor-interacting proteins in prostate cancer development and therapy resistance", Am J Pathol, 194, pp.324~334 (2024)
  38. Rohira AD, "Emerging roles of steroid receptor coactivators in stromal cell responses", J Endocrinol, 248, pp.R41~50 (2021)
  39. Senapati D, "Functional implications and therapeutic targeting of androgen response elements in prostate cancer", Biochimie, 214, pp.188~198 (2023)

관련 논문AI추천

Mixture of Corni Fructus and Schisandrae Fructus improves testosterone-induced benign prostatic hyperplasia through regulating 5α-reductase 2 and androgen receptor김기영, 최영현, Hwangbo Hyun, Ji Seon Yeong, Jung Haeun, Kim Hyunjin, Kim Min Yeong, Kim Sung Yeon, Kim TaeHee, Kim Taeiung, Lee Hyesook, Park Beom Su, Yoon Seonhye한국영양학회 · Nutrition Research and Practice2023 · 제17권 제1호Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats박철, 권다혜, 김경일, 김기영, 김민영, 김범회, 김종식, 박노진, 안규임, 정지숙, 지선영, 최영현, 최은옥, 홍수현, 황보현한국영양학회 · Nutrition Research and Practice2018 · 제12권 제5호Ameliorative effect of Abeliophyllum distichum Nakai on benign prostatic hyperplasia in vitro and in vivo김은경, 이상무, Bae Sung Mun, Choi Young-Jin, Fan Meiqi, Lee Bokyung, Lee Seung-Hyun, Moon Sangho, Tang Yujiao한국영양학회 · Nutrition Research and Practice2022 · 제16권 제4호海金沙가 Rat의 전립선비대에 미치는 영향김용성, 이두현, 이장식대한한방내과학회 · 대한한방내과학회지2010 · 제31권 제3호Influence of Panax ginseng on Alpha-Adrenergic Receptor of Benign Prostatic Hyperplasia김수강, 김영옥, 이강효, 이병철, 이상원, 정주호대한배뇨장애요실금학회 · International Neurourology Journal2014 · 제18권 제4호The combination of water extracts of Curcumae Radix and Syzygii Flos improves benign prostatic hyperplasia by suppressing testosterone-induced proliferation of prostate cells in vivo and in vitro곽현정, 박자연, Beomsu Lee, Gahee Song, Jae-Young Um, Jinbong Park, Kwang Seok Ahn, Woo Yong Park, Yunu Jung한국영양학회 · Nutrition Research and Practice2025 · 제19권 제3호

이 간행물의 다른 논문 (11건)